Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Adelman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Obstetrics and Gynecology|December 1, 1973
Postpartum bilateral femoral neuropathyJ U Adelman, G S Goldberg, J D Puckett
Headache|June 10, 2000
Rizatriptan tablet versus wafer: patient preferenceJ U Adelman, L K Mannix, R L Von Seggern
Headache|August 12, 2000
Cardiac risk factors and the use of triptans: a survey studyW B Young, L Mannix, J U Adelman, et al.
Headache|August 12, 2000
Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical settingL C Adelman, J U Adelman, R Von Seggern, et al.
Cephalalgia : an International Journal of Headache|January 7, 1999
Migraine preventive medications: a reappraisalJ U Adelman, A Brod, R L Von Seggern, et al.
Headache|April 12, 2000
Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1)B C Martin, D S Pathak, M I Sharfman, et al.
Neurology|October 24, 2001
Comparison of rizatriptan and other triptans on stringent measures of efficacyJ U Adelman, R B Lipton, M D Ferrari, et al.
Cephalalgia : an International Journal of Headache|February 18, 2009
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover studyR B Lipton, D W Dodick, J U Adelman, et al.
Neurology|December 31, 1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study GroupA M Rapoport, N M Ramadan, J U Adelman, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Obstetrics and Gynecology|December 1, 1973
Postpartum bilateral femoral neuropathyJ U Adelman, G S Goldberg, J D Puckett
Headache|June 10, 2000
Rizatriptan tablet versus wafer: patient preferenceJ U Adelman, L K Mannix, R L Von Seggern
Headache|August 12, 2000
Cardiac risk factors and the use of triptans: a survey studyW B Young, L Mannix, J U Adelman, et al.
Headache|August 12, 2000
Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical settingL C Adelman, J U Adelman, R Von Seggern, et al.
Cephalalgia : an International Journal of Headache|January 7, 1999
Migraine preventive medications: a reappraisalJ U Adelman, A Brod, R L Von Seggern, et al.
Headache|April 12, 2000
Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1)B C Martin, D S Pathak, M I Sharfman, et al.
Neurology|October 24, 2001
Comparison of rizatriptan and other triptans on stringent measures of efficacyJ U Adelman, R B Lipton, M D Ferrari, et al.
Cephalalgia : an International Journal of Headache|February 18, 2009
Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover studyR B Lipton, D W Dodick, J U Adelman, et al.
Neurology|December 31, 1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study GroupA M Rapoport, N M Ramadan, J U Adelman, et al.
Pageof 2